Genomics company Illumina (NASDAQ:ILMN) will be reporting earnings this Thursday afternoon. Here’s what to expect. Illumina ...

What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) jumped 3.7% in the pre-market session after analysts at ...

Image of Cathie Wood via Wikimedia Commons. In a market dominated by headlines about artificial intelligence (AI), cloud ...

According to the Adhishthana Principles, Illumina stock may remain under pressure for over 18 years — here's why.

The stock's fall snapped a five-day winning streak.

Barclays lowered their target price on Illumina from $100.00 to $77.00 and set an “underweight” rating on the stock in a report on Thursday, April 10th.

Illumina (NASDAQ:ILMN) stock dips as Scotiabank downgrades. However, peers Danaher (DHR) stock and Thermo Fisher (TMO) stock win upgrades. Read more here.

Barclays dropped their price objective on shares of Illumina from $100.00 to $77.00 and set an “underweight” rating for the company in a report on Thursday, April 10th.

Shares of Illumina Inc. ILMN advanced 1.00% to $91.52 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.11% to 6,092.18 ...

Illumina’s Q1 Revenues Revenues amounted to $1.04 billion, down 1.4% year over year and flat on a constant-currency basis. However, the top line beat the Zacks Consensus Estimate by 0.2% ...